Pain alliance with Evotec

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) and APEIRON Biologics AG today announced that they have entered into a collaboration to identify small molecule modulators of DREAM (Downstream Regulatory Element Antagonistic Modulator), a novel target involved in perception of various pain mechanisms. Press release Presseaussendung

October 27, 2010
View the Post

European Biotechnica Award 2010

Apeiron among the three finalists nominated for the EUROPEAN BIOTECHNICA AWARD 2010. Other finalists are listed companies Addex Pharmaceuticals (Switzerland) and Galapagos Genomics (Belgium).

October 4, 2010
View the Post

Biotech-Pharma Partnerships

LISA VR Press Talk: current partnerships between biotech and pharma in Vienna. LISA VR Press Talk

April 30, 2010
View the Post